24
Participants
Start Date
May 24, 2022
Primary Completion Date
August 25, 2023
Study Completion Date
August 25, 2023
Rapamune
We will start the dose at 0.5mg capsule every other day for 2 weeks. If participants tolerate this dose and trough blood levels are (≤4ng/mL), the dose of rapamycin will be increased to 0.5mg daily for the duration of the study. If necessary, dose can remain at 0.5 mg every other day, depending on the trough level. To avoid immunosuppression, we will target lower dose of rapamycin, maintain lower trough serum levels (≤4ng/mL).
Mayo Clinic Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER